Both Retatrutide and tirzepatide are GLP-1 agonists, but Retatrutide adds GCG-targeting capability, potentially enhancing weight loss results
Interestingly, tirzepatide displays similar activity to native GIP at the GIP receptor, but has lower affinity and potency than GLP-1 at the GLP-1R, suggesting it favors GIPR signaling (Gasbjerg et al., 2023
Before starting enclomiphene therapy, many patients experience symptoms associated with low testosterone, including: Low testosterone levels can affect both men and women, though symptoms and severity can vary based on individual hormone profiles
Step 6: Release the lock and press the button
Microdosing semaglutide could be your answer, offering gentler weight loss without the nausea and fatigue